Propolis extracts exhibit an immunoregulatory activity in an OVA-sensitized airway inflammatory animal model

International Immunopharmacology

Volumn 6, Issue 7, 2006, Pages 1053-1060

  Sy, Leticia B ^a,f   Wu, Yu Ling ^b   Chiang, Bor Luen ^c   Wang, Yao Horng ^d,e   Wu, Wen Mein ^b  

^a CARDINAL TIEN HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Asthma; Cytokine; Immunomodulation; Ovalbumin; Propolis extracts

Indexed keywords

ANTIGEN; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 5; INTERLEUKIN 6; OVALBUMIN; PROPOLIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG ACTIVITY; EOSINOPHIL; FEMALE; IMMUNIZATION; IMMUNOREGULATION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SPLEEN CELL; TUBE FEEDING;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES, CC; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LEUKOCYTE COUNT; MICE; MICE, INBRED BALB C; OVALBUMIN; PNEUMONIA; PROPOLIS; SPLEEN;

EID: 33646741211     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.01.015     Document Type: Article

References (28)

1. Maddox L., and Schwartz D.A. The pathophysiology of asthma. Annu Rev Med 53 (2002) 477-498
2. + T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am J Respir Crit Care Med 157 (1998) 210-218
3. Gonzalo J.A., Lloyd C.M., Kremer L., Finger E., Martinez-A C., Siegelman M.H., et al. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest 98 (1996) 2332-2345
4. Takeda K., Hamelmann E., Joetham A., Shultz L.D., Larsen G.L., Irvin C.G., et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 186 (1997) 449-454
5. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17 (1999) 255-281
6. Romagnani S. The Th1/Th2 paradigm. Immunol Today 18 (1997) 263-266
7. Ghisalberti E.L. Propolis: a review. Bee World 60 (1979) 59-84
8. Volpert R., and Elstner E.F. Biochemical activities of propolis extracts: I. Standardization and antioxidative properties of ethanolic and aqueous derivatives. Z Naturforsch 48 (1993) 851-857
9. Rapta P., Misik V., Stasko A., and Vrabel I. Redox intermediates of flavonoids and caffeic acid esters from propolis: an EPR spectroscopy and cyclic voltammetry study. Free Radic Biol Med 18 (1995) 901-908
10. Salomao K., Dantas A.P., Borba C.M., Campos L.C., Machado D.G., Aquino N.F., et al. Chemical composition and microbicidal activity of extracts from Brazilian and Bulgarian propolis. Lett Appl Microbiol 38 (2004) 87-92
11. Takagi Y., Choi I.S., Yamashita T., Nakamura T., Suzuki I., Hasegawa T., et al. Immune activation and radioprotection by propolis. Am J Chin Med 33 (2005) 231-240
12. Cieslewicz G., Tomkinson A., Alder A., Duez C., Schwarze J., Takeda K., et al. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophils infiltration. J Clin Invest 104 (1999) 301-308
13. Desmet C., Gosset P., Pajak B., Cataldo D., Bentires-Alj M., Lekeux P., et al. Selective blockade of NF-κB activity in airway immune cells inhibits the effector phase of experimental asthma. J Immunol 173 (2004) 5766-5775
14. Sakai K., Yokoyama A., Kohno N., and Hiwada K. Effect of different sensitizing doses of antigen in a murine model of atopic asthma. Clin Exp Immunol 118 (1999) 9-15
15. Brusasco V., and Crimi E. Methacholine provocation test for diagnosis of allergic respiratory diseases. Allergy 56 (2001) 1114-1120
16. Randolph D.A., Stephens R., Carruthers C.J., and Chaplin D.D. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J Clin Invest 104 (1999) 1021-1029
17. Tanaka H., Komai M., Nagao K., Ishizaki M., Kajiwara D., Takatsu K., et al. Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice. Am J Respir Cell Mol Biol 31 (2004) 62-68
18. Walker C., Bode E., Boer L., Hansel T.T., Blaser K., and Virchow Jr. J.C. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 146 (1992) 109-115
19. Borish L. IL-10: evolving concepts. J Allergy Clin Immunol 101 (1998) 293-297
20. Khayyal M.T., el-Ghazaly M.A., el-khatib A.S., Hatem A.M., de Vries P.J., el-Shafei S., et al. A clinical pharmacological study of the potential beneficial effects of a propolis food product as an adjuvant in asthmatic patients. Fundam Clin Pharmacol 17 (2003) 93-102
21. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 8 (1990) 253-278
22. Fitzpatrick L.R., Wang J., and Le T. Caffeic acid phenethyl ester, an inhibitor of nuclear factor-κB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats. J Pharmacol Exp Ther 299 (2001) 915-920
23. De Monchy J.G., Kauffman H.F., Venge P., Koeter G.H., Jansen H.M., Sluiter H.J., et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 131 (1985) 373-376
24. Nag S.S., Xu L.J., Hamid Q., and Renzi P.M. The effects of IL-5 on airway physiology and inflammation in rats. J Allergy Clin Immunol 111 (2003) 558-566
25. Tateno H., Nakamura H., Minematsu N., Amakawa K., Terashima T., Fujishima S., et al. Eotaxin and monocyte chemoattractant protein-1 in chronic eosinophilic pneumonia. Eur Respir J 17 (2001) 962-968
26. Menzies-Gow A., and Robinson D.S. Eosinophil chemokines and chemokine receptors: their role in eosinophil accumulation and activation in asthma and potential as therapeutic target. J Asthma 38 (2001) 605-613
27. Lopez A.F., Sanderson C.J., Gamble J.R., Campbell H.D., Young I.G., and Vadas M.A. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 167 (1988) 219-224
28. Foster P.S., Hogan S.P., Ramsay A.J., Mathaei K.I., and Young I.G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183 (1996) 195-201